title: Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
authors.forename: Ian J
authors.initials: IJ
authors.lastname: Clifton
authors.forename: Paul
authors.initials: P
authors.lastname: Whitaker
authors.forename: Rachel
authors.initials: R
authors.lastname: Metcalfe
authors.forename: Maria
authors.initials: M
authors.lastname: Phillip
authors.forename: Nicola
authors.initials: N
authors.lastname: Shaw
authors.forename: Steven P
authors.initials: SP
authors.lastname: Conway
authors.forename: Daniel G
authors.initials: DG
authors.lastname: Peckham
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy; D001232:Aspergillus fumigatus; D003550:Cystic Fibrosis / Q000150:complications / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D014230:Triazoles / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole